vs
REGIS CORP（RGS）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
RHYTHM PHARMACEUTICALS, INC.的季度营收约是REGIS CORP的1.1倍（$60.1M vs $57.1M），REGIS CORP净利率更高（0.8% vs -92.6%，领先93.4%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（83.8% vs 22.3%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（43.8% vs 7.8%）
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
RGS vs RYTM — 直观对比
营收规模更大
RYTM
是对方的1.1倍
$57.1M
营收增速更快
RYTM
高出61.5%
22.3%
净利率更高
RGS
高出93.4%
-92.6%
两年增速更快
RYTM
近两年复合增速
7.8%
损益表 — Q2 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $57.1M | $60.1M |
| 净利润 | $456.0K | $-55.6M |
| 毛利率 | — | 88.1% |
| 营业利润率 | 10.8% | -87.1% |
| 净利率 | 0.8% | -92.6% |
| 营收同比 | 22.3% | 83.8% |
| 净利润同比 | -94.0% | — |
| 每股收益（稀释后） | $0.16 | $-0.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RGSRYTM
| Q1 26 | — | $60.1M | ||
| Q4 25 | $57.1M | $57.3M | ||
| Q3 25 | $59.0M | $51.3M | ||
| Q2 25 | $60.4M | $48.5M | ||
| Q1 25 | $57.0M | $32.7M | ||
| Q4 24 | $46.7M | $41.8M | ||
| Q3 24 | $46.1M | $33.3M | ||
| Q2 24 | $49.4M | $29.1M |
净利润RGSRYTM
| Q1 26 | — | $-55.6M | ||
| Q4 25 | $456.0K | $-47.5M | ||
| Q3 25 | $1.4M | $-52.9M | ||
| Q2 25 | $116.5M | $-46.6M | ||
| Q1 25 | $250.0K | $-49.5M | ||
| Q4 24 | $7.6M | $-43.3M | ||
| Q3 24 | $-853.0K | $-43.6M | ||
| Q2 24 | $91.2M | $-32.3M |
毛利率RGSRYTM
| Q1 26 | — | 88.1% | ||
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% |
营业利润率RGSRYTM
| Q1 26 | — | -87.1% | ||
| Q4 25 | 10.8% | -82.2% | ||
| Q3 25 | 10.0% | -102.6% | ||
| Q2 25 | 12.1% | -93.4% | ||
| Q1 25 | 8.8% | -143.7% | ||
| Q4 24 | 11.8% | -98.6% | ||
| Q3 24 | 4.6% | -132.0% | ||
| Q2 24 | — | -139.2% |
净利率RGSRYTM
| Q1 26 | — | -92.6% | ||
| Q4 25 | 0.8% | -83.0% | ||
| Q3 25 | 2.3% | -103.1% | ||
| Q2 25 | 192.9% | -96.1% | ||
| Q1 25 | 0.4% | -151.4% | ||
| Q4 24 | 16.4% | -103.6% | ||
| Q3 24 | -1.9% | -131.2% | ||
| Q2 24 | 184.7% | -110.9% |
每股收益（稀释后）RGSRYTM
| Q1 26 | — | $-0.83 | ||
| Q4 25 | $0.16 | $-0.73 | ||
| Q3 25 | $0.49 | $-0.82 | ||
| Q2 25 | $43.67 | $-0.75 | ||
| Q1 25 | $0.08 | $-0.81 | ||
| Q4 24 | $2.71 | $-0.71 | ||
| Q3 24 | $-0.36 | $-0.73 | ||
| Q2 24 | $38.40 | $-0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.4M | $340.6M |
| 总债务越低越好 | $113.3M | — |
| 股东权益账面价值 | $188.7M | $122.9M |
| 总资产 | $588.3M | $442.3M |
| 负债/权益比越低杠杆越低 | 0.60× | — |
8季度趋势，按日历期对齐
现金及短期投资RGSRYTM
| Q1 26 | — | $340.6M | ||
| Q4 25 | $18.4M | $388.9M | ||
| Q3 25 | $16.6M | $416.1M | ||
| Q2 25 | $17.0M | $291.0M | ||
| Q1 25 | $13.3M | $314.5M | ||
| Q4 24 | $10.2M | $320.6M | ||
| Q3 24 | $6.3M | $298.4M | ||
| Q2 24 | $10.1M | $319.1M |
总债务RGSRYTM
| Q1 26 | — | — | ||
| Q4 25 | $113.3M | — | ||
| Q3 25 | $111.3M | — | ||
| Q2 25 | $110.8M | — | ||
| Q1 25 | $112.0M | — | ||
| Q4 24 | $111.5M | — | ||
| Q3 24 | $95.2M | — | ||
| Q2 24 | $99.5M | — |
股东权益RGSRYTM
| Q1 26 | — | $122.9M | ||
| Q4 25 | $188.7M | $139.1M | ||
| Q3 25 | $187.6M | $148.8M | ||
| Q2 25 | $185.6M | $-11.9M | ||
| Q1 25 | $68.6M | $18.9M | ||
| Q4 24 | $66.7M | $21.7M | ||
| Q3 24 | $56.4M | $11.2M | ||
| Q2 24 | $56.8M | $39.3M |
总资产RGSRYTM
| Q1 26 | — | $442.3M | ||
| Q4 25 | $588.3M | $480.2M | ||
| Q3 25 | $592.1M | $506.9M | ||
| Q2 25 | $599.0M | $372.7M | ||
| Q1 25 | $511.2M | $386.7M | ||
| Q4 24 | $530.1M | $392.3M | ||
| Q3 24 | $508.9M | $363.6M | ||
| Q2 24 | $530.5M | $381.8M |
负债/权益比RGSRYTM
| Q1 26 | — | — | ||
| Q4 25 | 0.60× | — | ||
| Q3 25 | 0.59× | — | ||
| Q2 25 | 0.60× | — | ||
| Q1 25 | 1.63× | — | ||
| Q4 24 | 1.67× | — | ||
| Q3 24 | 1.69× | — | ||
| Q2 24 | 1.75× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.7M | — |
| 自由现金流经营现金流 - 资本支出 | $891.0K | — |
| 自由现金流率自由现金流/营收 | 1.6% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | 3.65× | — |
| 过去12个月自由现金流最近4个季度 | $14.9M | — |
8季度趋势，按日历期对齐
经营现金流RGSRYTM
| Q1 26 | — | — | ||
| Q4 25 | $1.7M | $-25.4M | ||
| Q3 25 | $2.3M | $-26.6M | ||
| Q2 25 | $6.8M | $-23.3M | ||
| Q1 25 | $6.2M | $-40.4M | ||
| Q4 24 | $2.1M | $-18.8M | ||
| Q3 24 | $-1.3M | $-25.2M | ||
| Q2 24 | $5.1M | $-29.1M |
自由现金流RGSRYTM
| Q1 26 | — | — | ||
| Q4 25 | $891.0K | — | ||
| Q3 25 | $1.9M | — | ||
| Q2 25 | $6.2M | — | ||
| Q1 25 | $5.9M | — | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $-1.4M | — | ||
| Q2 24 | $5.1M | — |
自由现金流率RGSRYTM
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | — | ||
| Q3 25 | 3.2% | — | ||
| Q2 25 | 10.3% | — | ||
| Q1 25 | 10.3% | — | ||
| Q4 24 | 3.6% | — | ||
| Q3 24 | -3.0% | — | ||
| Q2 24 | 10.3% | — |
资本支出强度RGSRYTM
| Q1 26 | — | — | ||
| Q4 25 | 1.4% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — |
现金转化率RGSRYTM
| Q1 26 | — | — | ||
| Q4 25 | 3.65× | — | ||
| Q3 25 | 1.68× | — | ||
| Q2 25 | 0.06× | — | ||
| Q1 25 | 24.80× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.06× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
RYTM
暂无分部数据
